SAFETY OF USING METHOTREXATE SOLUTION FOR SUBCUTANEOUS INJECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Objective: to evaluate the safety of treatment with methotrexate (MT) solution for subcutaneous injections in patients with rheumatoid arthritis (RA).Subjects and methods. 237 RA patients enrolled in the study within the REMARCA protocol were given MT solution for subcutaneous injections (Metoject)...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yu. V. Muravyev, G. I. Gridneva, D. E. Karateev, E. L. Luchichina
Médium: Artigo
Jazyk:Russo
Vydáno: IMA-PRESS LLC 2015-09-01
Edice:Научно-практическая ревматология
Témata:
rheumatoid arthritis
safety
methotrexate solution for subcutaneous injections
adverse events
On-line přístup:https://rsp.mediar-press.net/rsp/article/view/2106
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky